Placental-derived mesenchymal stem cell (PD-MSC) modalities offer many potential benefits in the medical field. They are derived from the placenta, which is a natural, easily accessible source of stem cells. PD-MSCs have the potential to be used in regenerative medicine, tissue engineering, and cell therapy. They are capable of self-renewal and multipotent differentiation, making them a promising tool for treating a variety of diseases and conditions such as Alzheimer’s disease, Parkinson’s disease, stroke, heart disease, diabetes, and autoimmune disorders.
Benefits of PD-MSC modalities include:
PD-MSC modalities are being studied for their potential to treat a variety of diseases and conditions, and to this day, more research is being performed to further explore their potential.